Blueprint Medicines (NASDAQ:BPMC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Blueprint Medicines beat estimated earnings by 7.73%, reporting an EPS of $-1.79 versus an estimate of $-1.94.

Revenue was up $41.16 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.66 which was followed by a 7.75% drop in the share price the next day.

Here's a look at Blueprint Medicines's past performance:

To track all earnings releases for Blueprint Medicines visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.